Publication | Open Access

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

Hematological MalignancyChronic Myeloid LeukemiaMedicinePharmacologyKinase InhibitorsOncologyCell BiologyTumor BiologyMyeloid Neoplasia